Vulnerability · Published Aug 11, 2026 · Assigned by icscert
CVE-2026-68067Mira Hormone Monitor, Mira Android App Weak Authentication
Critical 9.8
In plain English
A critical-severity security flaw in Mira Android App from Quanovate Tech Inc. (operating as Mira / Mira Care). There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.5% (higher than 44% of all known vulnerabilities).
Severity (CVSS 3.1)9.8Critical
Exploit odds (30 days)0.5%top 56.2% of all CVEs
Exploited in the wildNo reportsCISA SSVC: none
Attack toolingNoneno public tooling known
Official description
The login endpoint on the Mira cloud API accepts any format-valid string in the password field and returns a live active session token for the account matching the supplied email address. An attacker could use an email address to control cloud accounts and access hormone record information and account settings.
Affected products (as reported)
| Vendor | Product | Versions |
|---|---|---|
| Quanovate Tech Inc. (operating as Mira / Mira Care) | Mira Firmware | 1.7.1.47 |
| Quanovate Tech Inc. (operating as Mira / Mira Care) | Mira Android App | 4.5.15.4 |
Weakness: CWE-1390 · Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H